NCT01470677View on ClinicalTrials.gov

Tachosil for the Prevention of Symptomatic Lymph Cysts

PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Endometrial CancerCervical Cancer

Interventions

DRUG

Tachosil fibrin patch

A Tachosil® patch of 4.8x4.8cm will be attached to the obturator fossa and a Tachosil® patch of 4.8x4.8cm will be attached to the femoral canal of each side of surgery in the intervention group. In the control group, no Tachosil® patch will be used. No specific drainage of the retroperitoneum will be performed.

Trial Locations (2)

A-1090

Medical University of Vienna, Vienna

D-44625

Ruhr University Bochum, Bochum

All Listed Sponsors

lead

Ruhr University of Bochum

OTHER

NCT01470677 - Tachosil for the Prevention of Symptomatic Lymph Cysts | Biotech Hunter | Biotech Hunter